Orchard to lose out on milestone payments as Pharming Group ends collab



Orchard received an upfront payment of $17.5 million for the deal with Pharming and could have received millions more for development, regulatory and sales milestones.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *